We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$54.1B
AUM Growth
+$9.43B
Cap. Flow
+$3.44B
Cap. Flow %
6.35%
Top 10 Hldgs %
12.03%
Holding
3,138
New
250
Increased
1,399
Reduced
1,041
Closed
231

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.5M
2
JCI icon
Johnson Controls International
JCI
+$52.5M
3
EBAY icon
eBay
EBAY
+$49.8M
4
VTR icon
Ventas
VTR
+$46.6M
5
AAPL icon
Apple
AAPL
+$43.5M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Technology 14.94%
3 Healthcare 12.21%
4 Consumer Discretionary 10.01%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICBK
2976
DELISTED
County Bancorp, Inc. Common Stock
ICBK
-31,303
Closed -$544K
INOV
2977
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-6,491
Closed -$92K
XOG
2978
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
-126,578
Closed -$544K
HOME
2979
DELISTED
At Home Group Inc.
HOME
-46,974
Closed -$876K
CLCT
2980
DELISTED
Collectors Universe
CLCT
-46,509
Closed -$528K
EIDX
2981
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
-15,442
Closed -$213K
ARA
2982
DELISTED
American Renal Associates Holdings, Inc
ARA
-37,886
Closed -$439K
IMMU
2983
DELISTED
Immunomedics Inc
IMMU
-77,502
Closed -$1.11M
AIMT
2984
DELISTED
Aimmune Therapeutics
AIMT
-25,614
Closed -$612K
TLRD
2985
DELISTED
Tailored Brands, Inc.
TLRD
-80,666
Closed -$1.1M
TTPH
2986
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-590
Closed -$14K
PTLA
2987
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-285,165
Closed -$5.46M
TSG
2988
DELISTED
The Stars Group Inc.
TSG
-30,730
Closed -$508K
MLNX
2989
DELISTED
Mellanox Technologies, Ltd.
MLNX
-18,800
Closed -$1.74M
OMN
2990
DELISTED
OMNOVA Solutions Inc.
OMN
-2,037
Closed -$15K
IPHS
2991
DELISTED
Innophos Holdings, Inc.
IPHS
-6,578
Closed -$161K
CBPX
2992
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
-3,062
Closed -$78K
ENFC
2993
DELISTED
Entegra Financial Corp.
ENFC
-10,573
Closed -$220K
LKSD
2994
DELISTED
LSC Communications, Inc.
LKSD
-4,111
Closed -$29K
APU
2995
DELISTED
AmeriGas Partners, L.P.
APU
-12,082
Closed -$306K
HF
2996
DELISTED
HFF Inc.
HF
-4,596
Closed -$153K
LABL
2997
DELISTED
Multi-Color Corp
LABL
-4,487
Closed -$157K
LION
2998
DELISTED
Fidelity Southern Corporation
LION
-18,096
Closed -$471K
LXFT
2999
DELISTED
Luxoft Holding, Inc.
LXFT
-64,146
Closed -$1.96M
TIER
3000
DELISTED
TIER REIT, Inc.
TIER
-21,009
Closed -$433K

Similar funds

Russell Investments Group's Q1 2019 Portfolio in Review

As of Q1 2019, Russell Investments Group held 3,138 positions worth $54.1B, up 21% from $44.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Russell Investments Group deployed $3.44B of net new capital in Q1 2019, opening 250 new positions and adding to 1,399 existing holdings. Its largest new stake was American Electric Power Company, Inc. Corporate Unit: 4,210,194 shares worth $2.15M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Celgene Corp, an estimated $75.5M trimmed.

  • Russell Investments Group's largest Q1 2019 buy was American Electric Power Company, Inc. Corporate Unit: 4,210,194 shares worth $2.15M.
  • Russell Investments Group added most to JPMorgan Chase in Q1 2019, an estimated $93.6M increase.
  • Russell Investments Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.5M.
  • Russell Investments Group fully exited Aerie Pharmaceuticals in Q1 2019, selling an estimated $13.5M.
  • Russell Investments Group's ten largest holdings make up 12% of its $54.1B portfolio in Q1 2019.
  • Russell Investments Group opened 250 new positions and closed 231 in Q1 2019.
  • Russell Investments Group's portfolio value rose 21% quarter-over-quarter to $54.1B.

Based on Russell Investments Group's 13F filing for Q1 2019, filed 13 May 2019.